Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Joseph

Showing results (181-190 of 295) with videos related to

Pageof 30
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 31, 2010
A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trialDavid S Lamb, James W Denham, David Joseph, et al.
Cancer|August 20, 2009
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?James W Denham, Allison Steigler, Chantelle Wilcox, et al.
Pathology|May 5, 2010
Gleason scoring: a comparison of classical and modified (international society of urological pathology) criteria using nadir PSA as a clinical end pointBrett Delahunt, David S Lamb, John R Srigley, et al.
Seminars in Radiation Oncology|April 6, 2005
TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiationJayant S Vaidya, Jeffrey S Tobias, Michael Baum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2018
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03Michael MacManus, Richard Fisher, Daniel Roos, et al.
Medicine and Science in Sports and Exercise|November 6, 2018
Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer PatientsRobert U Newton, Daniel A Galvão, Nigel Spry, et al.
Journal of Clinical Pharmacology|August 17, 2018
Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune DiseasesChristian Schwabe, Bernd Rosenstock, Thi Doan, et al.
Journal of Gastroenterology and Hepatology|July 23, 2011
Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk IndexEsther L de Graaf, James Kench, Pamela Dilworth, et al.
Annals of Surgery|September 16, 2016
Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)Nabila Ansari, Michael J Solomon, Richard J Fisher, et al.
Journal of Pediatric Rehabilitation Medicine|November 11, 2017
Bowel management and continence in adults with spina bifida: Results from the National Spina Bifida Patient Registry 2009-15John S Wiener, Kristina D Suson, Jonathan Castillo, et al.
Pageof 30

Showing results (181-190 of 295) with videos related to

Sort By:
Pageof 30
International Journal of Radiation Oncology, Biology, Physics|March 31, 2010
A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trialDavid S Lamb, James W Denham, David Joseph, et al.
Cancer|August 20, 2009
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival?James W Denham, Allison Steigler, Chantelle Wilcox, et al.
Pathology|May 5, 2010
Gleason scoring: a comparison of classical and modified (international society of urological pathology) criteria using nadir PSA as a clinical end pointBrett Delahunt, David S Lamb, John R Srigley, et al.
Seminars in Radiation Oncology|April 6, 2005
TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiationJayant S Vaidya, Jeffrey S Tobias, Michael Baum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2018
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03Michael MacManus, Richard Fisher, Daniel Roos, et al.
Medicine and Science in Sports and Exercise|November 6, 2018
Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer PatientsRobert U Newton, Daniel A Galvão, Nigel Spry, et al.
Journal of Clinical Pharmacology|August 17, 2018
Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti-CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune DiseasesChristian Schwabe, Bernd Rosenstock, Thi Doan, et al.
Journal of Gastroenterology and Hepatology|July 23, 2011
Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk IndexEsther L de Graaf, James Kench, Pamela Dilworth, et al.
Annals of Surgery|September 16, 2016
Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)Nabila Ansari, Michael J Solomon, Richard J Fisher, et al.
Journal of Pediatric Rehabilitation Medicine|November 11, 2017
Bowel management and continence in adults with spina bifida: Results from the National Spina Bifida Patient Registry 2009-15John S Wiener, Kristina D Suson, Jonathan Castillo, et al.
Pageof 30